glp 1 for hair growth GLP-1 Medications & Loss: How Hair Extensions Can Help smooth frizz GLP-1 Medications and Hair Loss:

February 18, 2025

Retatrutide is investigational and not FDA-approved as of June 2026

Any deviation from licensed dosing regimens should only occur under close medical supervision, as the risk-benefit profile at sub-therapeutic doses remains poorly characterised and may not provide the intended clinical outcomes

Research from the SURMOUNT and STEP trials showed that up to 40 percent of the weight lost on GLP-1 medications can come from lean mass (muscle), not fat

A., Jimnez-Murcia, S., & Fernandez-Aranda, F

Evening GLP-1 injections: the case for nighttime dosing Evening dosing has a dedicated following, and the reasoning is surprisingly compelling